evidencegaps
Primary study · included by 1 review

Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial.

Li 2024 · Li Kezhen, Chen Jing, Hu Yingjie, et al. · The Lancet. Oncology · 2024

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.
Non-Cochrane · intervention · 2026 · cited as Li 2024 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.